Tirzepatide Prescribing at ROTHSCHILD HOUSE GROUP
Drugs used in diabetes | Endocrine System
Items (12m)
158
Total Quantity
191
NHS Cost
£17.9K
vs National Avg
-18.6%
ROTHSCHILD HOUSE GROUP prescribed 158 items of Tirzepatide over the last 12 months at a cost of £17,869 to the NHS. This is 18.6% below the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
1
Jun 2026
8
Jun 2026
8
Jun 2026
9
Jun 2026
9
Jun 2026
10
Jun 2026
12
Jun 2026
23
Jun 2026
25
Jun 2026
26
Jun 2026
27
Prescribing Details
| Total Items | 158 |
|---|---|
| Total Quantity | 191 |
| Total NHS Cost | £17,869 |
| Presentations | 8 different forms |
| vs National Average | -18.6% |
Tirzepatide Prescribing Comparison
| This practice | 158 items |
|---|---|
| National average per practice | 194 items |
| Difference | -18.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.